Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase-Rearranged Anaplastic Thyroid Carcinoma

MeSH terms

• Aged
• Anaplastic Lymphoma Kinase
• Antineoplastic Agents / therapeutic use*
• Biomarkers, Tumor / genetics*
• Biopsy
• Chemotherapy, Adjuvant
• Crizotinib
• Female
• Gene Rearrangement*
• Humans
• Immunohistochemistry
• In Situ Hybridization, Fluorescence
• Lung Neoplasms / drug therapy*
• Lung Neoplasms / enzymology
• Lung Neoplasms / genetics
• Lung Neoplasms / secondary
• Neoplasm Staging
• Precision Medicine
• Predictive Value of Tests
• Protein Kinase Inhibitors / therapeutic use*
• Pyrazoles / therapeutic use*
• Pyridines / therapeutic use*
• Receptor Protein-Tyrosine Kinases / antagonists & inhibitors*
• Receptor Protein-Tyrosine Kinases / genetics*
• Remission Induction
• Thyroid Carcinoma, Anaplastic / drug therapy*
• Thyroid Carcinoma, Anaplastic / enzymology
• Thyroid Carcinoma, Anaplastic / genetics
• Thyroid Carcinoma, Anaplastic / secondary
• Thyroid Neoplasms / drug therapy*
• Thyroid Neoplasms / enzymology
• Thyroid Neoplasms / genetics
• Thyroid Neoplasms / pathology
• Thyroidectomy
• Time Factors
• Tomography, X-Ray Computed
• Treatment Outcome